Case 2 demonstrates a rapid improvement in mood with tirzepatide dose titration that preceded significant weight loss
Individual insulin and glucose requirements, as well as the timing, intensity, and duration of exercise, must all be taken into consideration while developing strategies
MHRA Licensing and the ILAP Route Eli Lilly is expected to submit retatrutide to the MHRA for marketing authorization in late 2026 or early 2027
See If GLP-1 Treatment May Be Right for You A licensed provider can review your health history and weight-loss goals to help determine whether GLP-1 treatment is appropriate for you
Additionally, medical supervision ensures that weight loss occurs at a safe and sustainable rate, reducing the risk of muscle loss or nutritional deficiencies
B12 supports energy during caloric restriction Vitamin B12 is an essential cofactor for cellular energy production